Internal Medicine, Hematology & Oncology · Kinston, NC
NPI
1013992635
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
313 Airport Road
Kinston, NC, 28501
Phone (252) 559-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$418K
21,850 services
Medicare patients, 2024
396
Average age 74
Drug cost, 2024
$4.0M
2,205 prescriptions
Company payments, 2025
$298
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Misbah U Qadir was code 99214 (office e&m - established), 674 times for 137 patients. In total Misbah U Qadir billed 21,850 services in 110 codes, and Medicare paid $418K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 674 | 137 | $72.99 | $49K |
| 85025 Blood Count | Office | 302 | 100 | $7.61 | $2,298 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Facility | 272 | 67 | $70.22 | $19K |
| 80053 Clinical Chemistry | Office | 251 | 88 | $10.35 | $2,598 |
| 36415 Venipuncture Blood Collection | Office | 237 | 85 | $8.65 | $2,050 |
| 99214 Office E&M - Established | Office | 148 | 64 | $93.49 | $14K |
| 99213 Office E&M - Established | Facility | 134 | 81 | $41.79 | $5,599 |
| 99213 Office E&M - Established | Office | 95 | 75 | $56.50 | $5,368 |
| 99222 Hospital E&M - Initial | Facility | 76 | 73 | $102.43 | $7,785 |
| 99232 Hospital E&M - Subsequent | Facility | 65 | 38 | $61.28 | $3,983 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 57 | 17 | $73.24 | $4,175 |
| 82728 Clinical Chemistry | Office | 57 | 36 | $13.36 | $762 |
| 83550 Clinical Chemistry | Office | 57 | 36 | $8.57 | $488 |
| 96372 Injection Administration | Office | 52 | 11 | $10.51 | $547 |
| 83615 Clinical Chemistry | Office | 45 | 30 | $5.92 | $266 |
By year: 2022 $1.4M for 77,705 services; 2023 $474K for 24,735 services; 2024 $418K for 21,850 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 302 | 100 | $7.61 | $2,298 |
| 80053 Clinical Chemistry | 251 | 88 | $10.35 | $2,598 |
| 36415 Venipuncture Blood Collection | 237 | 85 | $8.65 | $2,050 |
| 82728 Clinical Chemistry | 57 | 36 | $13.36 | $762 |
| 83550 Clinical Chemistry | 57 | 36 | $8.57 | $488 |
| 83615 Clinical Chemistry | 45 | 30 | $5.92 | $266 |
| 82232 Clinical Chemistry | 25 | 13 | $15.86 | $397 |
| 82607 Clinical Chemistry | 22 | 17 | $14.78 | $325 |
Medicare prescription drug claims, 2024
In 2024, the drug Misbah U Qadir prescribed most often to Medicare patients was Oxycodone Hcl, with 134 prescriptions and refills. In total Misbah U Qadir wrote 2,205 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 134 | 135 | 31 | $1,847 |
| Dexamethasone Generic | 107 | 109 | 43 | $878 |
| Eliquis Apixaban | 92 | 96 | 19 | $54K |
| Prednisone Generic | 88 | 103 | 51 | $297 |
| Prochlorperazine Maleate Generic | 77 | 77 | 42 | $763 |
| Tagrisso Osimertinib Mesylate | 71 | 71 | Under 11 | $1.1M |
| Furosemide Generic | 60 | 72 | 14 | $144 |
| Potassium Chloride Generic | 57 | 72 | 20 | $821 |
| Anastrozole Generic | 57 | 79 | 11 | $986 |
| Gabapentin Generic | 56 | 63 | 13 | $413 |
| Letrozole Generic | 53 | 79 | 11 | $646 |
| Levothyroxine Sodium Generic | 46 | 73 | Under 11 | $187 |
| Alprazolam Generic | 46 | 48 | Under 11 | $84.31 |
| Duloxetine Hcl Generic | 45 | 62 | 12 | $438 |
| Lorazepam Generic | 40 | 40 | 16 | $90.31 |
Brand drugs: 525 claims; generic drugs: 1,680 claims; opioid claims: 275.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Misbah U Qadir $298 ($298 in general payments such as food, travel and fees) from 10 companies. The largest payer was Merck Sharp & Dohme LLC with $98.49.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 4 | $98.49 |
| Janssen Biotech, Inc. JNJ | 2 | $45.03 |
| Abbvie Inc. ABBV | 1 | $33.53 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $29.32 |
| Incyte Corporation INCY | 1 | $21.66 |
| Pfizer Inc. PFE | 1 | $19.11 |
| Astellas Pharma US Inc 4503.T | 1 | $18.9 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $16.19 |
| GlaxoSmithKline, LLC. GSK | 1 | $15.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.